Skip to content

Study · Measured the body's own peptide · 2013

1 result

Glycoprotein 130 promotes human blastocyst development in vitro.

Hambiliki F, Hanrieder J, Bergquist J, Hreinsson J, Stavreus-Evers A, Wånggren K

Fertility and sterility30 Jan 2013Cited by 5 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelEx vivo tissueMechanism

    In cultured human embryos, mass spectrometry showed significant intensity changes of thymosin beta‑4 among several molecular species, with no direction stated.

    In plain wordsIn cultured human embryos, the body's own thymosin beta‑4 level changed, among several other proteins. The direction was not stated.

    Outcome
    Direction not reportedThymosin beta-4 intensity in blastocyst protein spectra
    Study

    humann: not reported in source

    Cultured thawed human embryos (blastocysts)
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    Protein fingerprint spectra were obtained that revealed significant intensity changes for multiple molecular species including thymosin beta-10, thymosin beta-4, histone H2A, histone H2B, histone H4, ubiquitin, ubiquitin-T, and acyl-CoA binding protein.
    1 context sentence
    Summary · context
    A total of 164 frozen embryos that survived thawing were cultured in media supplemented with LIF and/or gp130 or control media.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.